Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 2, 2008, Pages 295-302

  Karakuş, Sevgi ^a   Küçükgüzel, Ilkay ^a   Küçükgüzel, Ş Güniz ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Cetirizine; Fexofenadine; Pseudoephedrine; Reversed phase HPLC; Validation

Indexed keywords

ALLEGRA D; CETIRIZINE; CIRRUS; FEXOFENADINE; PSEUDOEPHEDRINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CORRELATION COEFFICIENT; DRUG CAPSULE; DRUG DOSAGE FORM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET; VALIDATION PROCESS;

CETIRIZINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; HISTAMINE H1 ANTAGONISTS; PHARMACEUTICAL PREPARATIONS; PSEUDOEPHEDRINE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TERFENADINE;

EID: 37749021416     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.10.018     Document Type: Article

References (38)

1. Campoli-Richards D.M., Buckley M.M., and Fitton A. Drugs 40 (1990) 762-781
2. Curran M.P., Scott L.J., and Perry C.M. Drugs 64 (2004) 523-561
3. Spencer C.M., Faulds D., and Peters D.H. Drugs 46 (1993) 1055-1080
4. Pagliara A., Testa B., Carrupt P.A., Jolliet P., Morin C., Morin D., Urien S., Tillement J.P., and Rihoux J.P. J. Med. Chem. 41 (1998) 853-863
5. Wellington K., and Jarvis B. Drugs 61 (2001) 2231-2240
6. European Pharmacopeia 5.0, 5th edition, Council of Europe-European Directorate for the Quality of Medicines, 2005, pp.1237-1239.
7. Basavaiah K., and Charan V.S. Farmaco 57 (2002) 9-17
8. El Walily A.F.M., Korany M.A., El Gindy A., and Bedair M.F. J. Pharm. Biomed. Anal. 17 (1998) 435-442
9. Mahgoub H., Gazy A.A., El-Yazbi F.A., El-Sayed M.A., and Youssef R.M. J. Pharm. Biomed. Anal. 31 (2003) 801-809
10. Macek J., Ptáček P., and Klíma J. J. Chromatogr. B 736 (1999) 231-235
11. Zaater M.F., Tahboub Y.R., and Najib N.M. J. Pharm. Biomed. Anal. 22 (2000) 739-744
12. Paw B., Misztal G., Hopkala H., and Drozd J. Pharmazie 57 (2002) 313-315
13. Song Q., Junga H., Tang Y., Li A.C., Addison T., McCort-Tipton M., Beato B., and Naidong W. J. Chromatogr. B 814 (2005) 105-114
14. Likar M.D., Mansour H.L., and Harwood J.W. J. Pharm. Biomed. Anal. 39 (2005) 543-551
15. Choi S.O., Lee S.H., Kong H.S., Kim E.J., and Choo H.Y.P. J. Chromatogr. B 744 (2000) 201-206
16. Mikuš P., Valášková I., and Havránek E. J. Sep. Sci. 28 (2005) 1278-1284
17. Jaber A.M., Al Sherife H.A., Al Omari M.M., and Badwan A.A. J. Pharm. Biomed. Anal. 36 (2004) 341-350
18. Nagaralli B.S., Seetharamappa J., Gowda B.G., and Melwanki M.B. J. Chromatogr. B 798 (2003) 49-54
19. Pandya K.K., Bangaru R.A., Gandhi T.P., Modi I.A., Modi R.I., and Chakravarthy B.K. J. Pharm. Pharmacol. 48 (1996) 510-513
20. Makhija S.N., and Vavia P.R. J. Pharm. Biomed. Anal. 25 (2001) 663-667
21. Simpson K., and Jarvis B. Drugs 59 (2000) 301-321
22. Meeves S.G., and Appajosyula S. J. Allergy Clin. Immunol. 112 (2003) S69-S77
23. United States Pharmacopeia, 29th revision, US Pharmacopeial Convention, Rockville, MD, 2006, pp. 905-906.
24. Hofmann U., Seiler M., Drescher S., and Fromm M.F. J. Chromatogr. B 766 (2002) 227-233
25. Naidong W., Shou W.Z., Addison T., Maleki S., and Jiang X. Rapid Commun. Mass Spectrom. 16 (2002) 1965-1975
26. Uno T., Yasui-Furukori N., Takahata T., Sugawara K., and Tateishi T. J. Pharm. Biomed. Anal. 35 (2004) 937-942
27. Radhakrishna T., and Reddy G.O. J. Pharm. Biomed. Anal. 29 (2002) 681-690
28. Walker T.A., and Schmitt G.L. J. Liq. Chromatogr. Rel. Technol. 29 (2006) 25-43
29. Breier A.R., Paim C.S., Steppe M., and Schapoval E.E. J. Pharm. Pharm. Sci. 8 (2005) 289-298
30. Breier A.R., Garcia S.S., Jablonski A., Steppe M., and Schapoval E.E. J. AOAC Int. 88 (2005) 1059-1063
31. Mikuš P., Valášková I., and Havránek E. Drug Dev. Ind. Pharm. 31 (2005) 795-801
32. Sussman G.L., Mason J., Compton D., Stewart J., and Ricard N. J. Allergy Clin. Immunol. 104 (1999) 100-106
33. Berkowitz R.B., Woodworth G.G., Lutz C., Weiler K., Weiler J., Moss M., and Meeves S. Ann. Allergy Asthma Immunol. 89 (2002) 38-45
34. Altuntas T.G., Zanooz S.S., and Nebioglu D. J. Pharm. Biomed. Anal. 17 (1998) 103-109
35. Mabrouk M.M., El-Fatatry H.M., Hammad S., and Wahbi A.A.M. J. Pharm. Biomed. Anal. 33 (2003) 597-604
36. Snyder L.R., Glajch J.L., and Kirkland J.J. Practical HPLC method development (1988), John Wiley & Sons Inc., New York
37. ICH-Q2B Validation of Analytical Procedures: Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, 1996.
38. Krull I., and Swartz M. LCGC N. Am. 17 (1999) 244-246